NARACHI MICHAEL
SEC CIK 1380022 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | Dir | 40.4K | — | — | 5 | 2022-06-24 | 2026-05-14 |
Most active insiders at RARE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Horn Howard | CFO | — | $1.33M |
| 2 | KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| 3 | Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| 4 | Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| 5 | Pinion John Richard | See Remarks | — | $228.7K |
| 6 | Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| 7 | SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| 8 | Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| 9 | Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| 10 | Ray Amrit | Dir | — | — |
| 13 | NARACHI MICHAEL | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-18 18:35 | 2026-05-14 | RARE | Ultragenyx Pharmaceutical Inc. | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +7,751 | 40.4K | +24% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | Ultragenyx Pharmaceutical Inc. | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +5,740 | 32.7K | +21% | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | Ultragenyx Pharmaceutical Inc. | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +5,345 | 26.9K | +25% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | Ultragenyx Pharmaceutical Inc. | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +3,860 | 21.6K | +22% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | Ultragenyx Pharmaceutical Inc. | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +3,300 | 17.7K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations